Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for MariMed Inc. (MRMD : OTC)

• Company Description    MariMed Inc. is a multi-state cannabis operator. The Company develops, owns and manages seed to sale state-licensed cannabis facilities, which are models in horticultural principles, cannabis cultivation, cannabis-infused products and dispensary operations. Its products and brands, includes Betty's Eddies(R), Nature's Heritage(TM), Bourne Baking Co. and K-Fusion(R). MariMed Inc. is based in NORWOOD, Mass. Number of Employees: 923

• Price / Volume Information    Yesterday's Closing Price: $0.08 Daily Weekly Monthly 20 Day Moving Average: 675,714 shares Shares Outstanding: 402.95 (millions) Market Capitalization: $32.24 (millions) Beta: 1.35 52 Week High: $0.18 52 Week Low: $0.06 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 17.99% 18.59% 12 Week 15.94% 11.63% Year To Date -14.89% -24.52%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10 Oceana Way - Norwood,MA 02062 USA ph: 781-277-0007 fax: - ir@marimedinc.com http://www.marimedinc.com

• General Corporate Information    Officers Jon R. Levine - President and Chief Executive Officer Edward Gildea - Chairman of the Board and Director Mario Pinho - Chief Financial Officer David Allen - Director Eva Selhub - Director Peer Information MariMed Inc. (BJCT) MariMed Inc. (CADMQ) MariMed Inc. (APNO) MariMed Inc. (UPDC) MariMed Inc. (IMTIQ) MariMed Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 56782V107 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/04/26 Share - Related Items Shares Outstanding: 402.95 Most Recent Split Date: (:1) Beta: 1.35 Market Capitalization: $32.24 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.74 Price/Cash Flow: 3.46 Price / Sales: 0.20 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 5.84% vs. Previous Quarter: 6.19% ROE 06/30/26 - -10.71 03/31/26 - -5.00 12/31/25 - -5.85 ROA 06/30/26 - -2.58 03/31/26 - -1.29 12/31/25 - -1.58 Current Ratio 06/30/26 - 0.92 03/31/26 - 0.95 12/31/25 - 1.00 Quick Ratio 06/30/26 - 0.34 03/31/26 - 0.34 12/31/25 - 0.38 Operating Margin 06/30/26 - -3.17 03/31/26 - -1.62 12/31/25 - -2.03 Net Margin 06/30/26 - -9.13 03/31/26 - -7.82 12/31/25 - -8.94 Pre-Tax Margin 06/30/26 - -6.21 03/31/26 - -5.78 12/31/25 - -6.80 Book Value 06/30/26 - 0.11 03/31/26 - 0.12 12/31/25 - 0.13 Inventory Turnover 06/30/26 - 2.76 03/31/26 - 2.67 12/31/25 - 2.66 Debt-to-Equity 06/30/26 - 1.78 03/31/26 - 1.67 12/31/25 - 1.44 Debt-to-Capital 06/30/26 - 63.98 03/31/26 - 62.52 12/31/25 - 59.06

Powered by Zacks Investment Research ©